Literature DB >> 24380484

Current endovascular treatment options for central retinal arterial occlusion: a review.

Nitin Agarwal1, Nihar B Gala, Reza J Karimi, Roger E Turbin, Chirag D Gandhi, Charles J Prestigiacomo.   

Abstract

Central retinal artery occlusion, although relatively rare, is an ophthalmological emergency. If left untreated, complete blindness will ensue. Conventional therapies have not significantly improved outcomes compared with the natural history of the disease. Several case series of more recent endovascular approaches, such as intraarterial fibrinolysis, report successful outcomes. Still other studies regarding intraarterial fibrinolysis do not demonstrate any significantly better outcomes, with some even indicating increased complication rates. Therefore, the authors present a review of the current endovascular treatment options for central retinal artery occlusion.

Entities:  

Mesh:

Year:  2014        PMID: 24380484     DOI: 10.3171/2013.11.FOCUS13331

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  6 in total

1.  Acute retinal arterial ischemia.

Authors:  Michael Dattilo; Nancy J Newman; Valérie Biousse
Journal:  Ann Eye Sci       Date:  2018-06-06

2.  Reperfusion of occluded branch retinal arteries by transluminal Nd:YAG laser embolysis combined with intravenous thrombolysis of urokinase.

Authors:  Fang Chai; Shanshuang Du; Xiquan Zhao; Runsheng Wang
Journal:  Biosci Rep       Date:  2018-01-19       Impact factor: 3.840

3.  Intra-Arterial Thrombolysis for Acute Central Retinal Artery Occlusion: A Systematic Review and Meta-Analysis.

Authors:  Paul S Page; Nicolas K Khattar; Andrew C White; Alexander C Cambon; Guy N Brock; Shesh N Rai; Robert F James
Journal:  Front Neurol       Date:  2018-02-21       Impact factor: 4.003

4.  Evaluation of the Association between the Risk of Central Retinal Artery Occlusion and the Concentration of Environmental Air Pollutants.

Authors:  Andrzej E Grzybowski; Małgorzata K Mimier
Journal:  J Clin Med       Date:  2019-02-07       Impact factor: 4.241

5.  Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation.

Authors:  Tsutomu Igarashi; Koichi Miyake; Maika Kobayashi; Shuhei Kameya; Chiaki Fujimoto; Kenji Nakamoto; Hisatomo Takahashi; Toru Igarashi; Noriko Miyake; Osamu Iijima; Yukihiko Hirai; Takashi Shimada; Takashi Okada; Hiroshi Takahashi
Journal:  Mol Vis       Date:  2016-07-16       Impact factor: 2.367

6.  Rescue vitrectomy with blocked artery massage and bloodletting for branch retinal artery occlusion.

Authors:  Chun-Ju Lin; Cheng-Wen Su; Huan-Sheng Chen; Wen-Lu Chen; Jane-Ming Lin; Yi-Yu Tsai
Journal:  Indian J Ophthalmol       Date:  2017-04       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.